136 related articles for article (PubMed ID: 28769289)
21. [Effect of bezafibrate in isolated hypercholesterolemia and mixed hyperlipidemia on infarct risk (Stepwise Program for Individual Risk Identification and Therapy): an open multicenter study].
Sinzinger H; Virgolini I; Kudlacek P
Wien Klin Wochenschr; 1991; 103(13):381-7. PubMed ID: 1897230
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin intervention mitigates hypercholesterolemia-induced alveolar bone resorption in rats.
Gao X; Zhou J; Bian Y; Huang S; Zhang D
Exp Ther Med; 2021 Jun; 21(6):628. PubMed ID: 33936284
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia.
Tavridou A; Efthimiadis A; Efthimiadis I; Manolopoulos VG
Heart Vessels; 2010 Jul; 25(4):288-93. PubMed ID: 20676836
[TBL] [Abstract][Full Text] [Related]
24. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
[TBL] [Abstract][Full Text] [Related]
25. Serum leptin levels in patients with hyperlipidemias.
Haluzík M; Fiedler J; Nedvídková J; Ceska R
Nutrition; 2000 Jun; 16(6):429-33. PubMed ID: 10869898
[TBL] [Abstract][Full Text] [Related]
26. Severe hypercholesterolemia in a patient with very low albumin and normal renal function.
Varughese MG; Deshotels MR; Zhang L; Ballantyne CM
J Clin Lipidol; 2023; 17(1):64-67. PubMed ID: 36411186
[TBL] [Abstract][Full Text] [Related]
27. Effect of fenofibrate on serum lipoproteins in subjects with familial hypercholesterolemia and combined hyperlipidemia.
Weisweiler P; Merk W; Janetschek P; Schwandt P
Atherosclerosis; 1984 Dec; 53(3):321-5. PubMed ID: 6529448
[TBL] [Abstract][Full Text] [Related]
28. Gender and Age Impact on the Association Between Thyroid-Stimulating Hormone and Serum Lipids.
Meng Z; Liu M; Zhang Q; Liu L; Song K; Tan J; Jia Q; Zhang G; Wang R; He Y; Ren X; Zhu M; He Q; Wang S; Li X; Zheng W; Hu T; Liu N; Upadhyaya A; Zhou P; Zhang J
Medicine (Baltimore); 2015 Dec; 94(49):e2186. PubMed ID: 26656346
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia.
Grundy SM; Ahrens EH; Salen G; Schreibman PH; Nestel PJ
J Lipid Res; 1972 Jul; 13(4):531-51. PubMed ID: 5041275
[TBL] [Abstract][Full Text] [Related]
30. Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice.
Tóth ME; Dukay B; Hoyk Z; Sántha M
Curr Pharm Des; 2020; 26(13):1486-1494. PubMed ID: 32067608
[TBL] [Abstract][Full Text] [Related]
31. [Retrospective study on 778 patients with acute myocardial infarct: relation between sex, age and blood lipid picture].
Callegari S; Andreoli L; Arsenio L; Strata A
Acta Biomed Ateneo Parmense; 1986; 57(5-6):141-53. PubMed ID: 2955619
[TBL] [Abstract][Full Text] [Related]
32. Hyperlipidemia: a novel etiologic factor in deep vein thrombosis.
Kawasaki T; Kambayashi J; Sakon M
Thromb Res; 1995 Jul; 79(2):147-51. PubMed ID: 7676401
[TBL] [Abstract][Full Text] [Related]
33. Clinical inquiries. When should we screen children for hyperlipidemia?
Misicko NE; St Anna L; Foliaco W
J Fam Pract; 2006 Aug; 55(8):723-5. PubMed ID: 16882449
[TBL] [Abstract][Full Text] [Related]
34. [Hyperlipidemia - side-effect of "Atypical" neuroleptics?].
Wetterling T
Fortschr Neurol Psychiatr; 2003 Oct; 71(10):535-40. PubMed ID: 14551854
[TBL] [Abstract][Full Text] [Related]
35. A moderate-fat diet for combined hyperlipidemia and metabolic syndrome.
Knopp RH; Fish B; Dowdy A; Retzlaff B; Walden C; Rusanu I; Paramsothy P
Curr Atheroscler Rep; 2006 Nov; 8(6):492-500. PubMed ID: 17045076
[TBL] [Abstract][Full Text] [Related]
36. Hyperlipidemia - a diabetic emergency.
Saudek CD
Geriatrics; 1982 Feb; 37(2):81-9. PubMed ID: 7056473
[TBL] [Abstract][Full Text] [Related]
37. [Primary hypercholesterolemia other than familial hypercholesterolemia and familial combined hyperlipidemia].
Arai H
Nihon Rinsho; 2007 Jul; 65 Suppl 7():321-5. PubMed ID: 17824050
[No Abstract] [Full Text] [Related]
38. Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism.
Bertolotti M; Del Puppo M; Corna F; Anzivino C; Gabbi C; Baldelli E; Carulli L; Loria P; Galli Kienle M; Carulli N
Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):823-30. PubMed ID: 21546230
[TBL] [Abstract][Full Text] [Related]
39. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.
Pihlajamäki J; Karjalainen L; Karhapää P; Vauhkonen I; Laakso M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):164-70. PubMed ID: 10634813
[TBL] [Abstract][Full Text] [Related]
40. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight.
Baila-Rueda L; Cenarro A; Lamiquiz-Moneo I; Perez-Calahorra S; Bea AM; Marco-Benedí V; Jarauta E; Mateo-Gallego R; Civeira F
J Nutr Biochem; 2018 Mar; 53():48-57. PubMed ID: 29190549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
